Skip to Main Content



  • Co-Director

    Dr. Pittenger is Professor and Assistant Chair for Translational Research in the Department of Psychiatry at Yale. He holds a Ph.D. in neurobiology, earned under the tutelage of Nobel Prize winning psychiatrist Eric Kandel. Dr. Pittenger has a long history of cutting-edge, collaborative, and trans-disciplinary research, which continues in this Center.
  • Co-Director

    Dr. Kelmendi is Assistant Professor of Psychiatry. He has been a key driver of psychedelic studies at Yale. He is as a co-founder of the Yale Psychedelic Science Interest Group, principal investigator (together with Dr. Pittenger) of the first controlled study of psilocybin in the treatment of obsessive-compulsive disorder, and a co-investigator on a major multi-site study of psilocybin in the treatment of depression, sponsored by the Usona Institute.  Dr. Kelmendi is on the Board of the Heffter Foundation, a major sponsor of work in psychedelic science.

Advisory Board

  • Vikram Sodhi ’94 Professor of Psychiatry; Chair, Research and Development Committee; Director Schizophrenia Neuropharmacology Research Group at Yale (SNRGY); Director, Neurobiological Studies Unit, VACHS; Director, VA-CMHC Schizophrenia Research Clinic; Director, Yale Center for the Science of Cannabis and Cannabinoids

  • George D. and Esther S. Gross Professor of Psychiatry; Director, Yale Depression Research Program; Co-Director, Yale New Haven Hospital Interventional Psychiatry Service

  • Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry, of Neuroscience, and of Psychology; Co-Director, Yale Center for Clinical Investigation; Chair, Psychiatry; Physician-in-Chief of Psychiatry, Yale New Haven Hospital; Director: NIAAA Center for the Translational Neuroscience of Alcoholism; Director, Clinical Neuroscience Division, VA National Center for PTSD


Research Staff